Cubist Systematic Strategies, LLC Mckesson Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$479.06 - $630.38 $5.89 Million - $7.75 Million	12,300 Added 57.21%	33,800 $16.7 Million
Q2 2024 Aug 14, 2024	BUY	$518.81 - $607.81 $881,976 - $1.03 Million	1,700 Added 8.59%	21,500 $12.6 Million
Q1 2024 May 15, 2024	BUY	$473.42 - $539.26 $3.12 Million - $3.56 Million	6,600 Added 50.0%	19,800 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $4.9 Million - $5.27 Million	11,200 Added 560.0%	13,200 $6.11 Million
Q3 2023 Nov 14, 2023	SELL	$402.4 - $446.42 $684,080 - $758,914	-1,700 Reduced 45.95%	2,000 $869,000
Q2 2023 Aug 14, 2023	SELL	$354.01 - $427.31 $7.4 Million - $8.93 Million	-20,900 Reduced 84.96%	3,700 $1.58 Million
Q1 2023 May 15, 2023	SELL	$335.35 - $386.06 $8.52 Million - $9.81 Million	-25,400 Reduced 50.8%	24,600 $8.76 Million
Q4 2022 Feb 14, 2023	SELL	$346.68 - $397.58 $15.8 Million - $18.1 Million	-45,500 Reduced 47.64%	50,000 $18.8 Million
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $1.06 Million - $1.23 Million	3,300 Added 3.58%	95,500 $32.5 Million
Q2 2022 Aug 15, 2022	BUY	$300.57 - $336.42 $27.7 Million - $31 Million	92,200 New	92,200 $30.1 Million

1,690

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $89.8B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.